propamidine isetionate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
propamidine isetionate: clinical details
Prescribing considerations
- Confirm symptoms are consistent with a minor superficial eye infection; worsening symptoms or visual disturbance require reassessment.
- The preserved formulation contains benzalkonium chloride, which can irritate dry eyes and affect the tear film or compromised cornea.
- Acanthamoeba keratitis is a non-licensed, specialist-managed indication requiring consultant ophthalmology involvement.
Contraindications and cautions
- Hypersensitivity to propamidine isetionate or any formulation component.
Monitoring
- Assess for worsening redness, pain, irritation or visual disturbance.
- Monitor the corneal surface where use is prolonged, particularly in dry-eye disease or a compromised cornea.
- No routine systemic laboratory monitoring is specified.
Clinical pharmacology
Propamidine is an aromatic diamidine with bacteriostatic action against a range of organisms. Activity is retained in organic material such as tissue fluid, pus and serum. Product-specific pharmacokinetic data are unavailable.
Formulation and product differences
- The selected product is a multidose eye-drop solution preserved with benzalkonium chloride.
- Other excipients include ammonium chloride, sodium chloride, sodium hydroxide and water for injections.
- The bottle may be supplied with a separate administration aid. It should not be confused with dibrompropamidine eye ointment, which contains a different active ingredient.
propamidine isetionate interactions
No interactions with other medicines are known from the selected UK SmPC. Tell a pharmacist or prescriber about other eye preparations so their administration can be coordinated.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.